Pharmaceuticals and Healthcare Reports China Dyslipidemia Market Zum Anzeigen klicken
  • Kommentare

Pharmaceuticals and Healthcare Reports

China Dyslipidemia Market

Veröffentlicht am in "Gesundheit & Fitness, Gesundheit & Fitness", Sprache — English. 3 Seiten.
More so than in any other market, the statins dominated Chinese dyslipidemia drugs sales in the 2013 base year, contributing 84% to the total market share, reflecting sales of $1.7 billion in total sales Mehr anzeigen
KOSTENLOSES Abonnement

Andere Publikationen von "Pharmaceuticals and Healthcare Reports"

Alle Publikationen anzeigen